Integrative Genome Comparison of Primary and Metastatic Melanomas

Roswell Park Cancer Institute, United States of America
PLoS ONE (Impact Factor: 3.23). 05/2010; 5(5):e10770. DOI: 10.1371/journal.pone.0010770
Source: PubMed


A cardinal feature of malignant melanoma is its metastatic propensity. An incomplete view of the genetic events driving metastatic progression has been a major barrier to rational development of effective therapeutics and prognostic diagnostics for melanoma patients. In this study, we conducted global genomic characterization of primary and metastatic melanomas to examine the genomic landscape associated with metastatic progression. In addition to uncovering three genomic subclasses of metastastic melanomas, we delineated 39 focal and recurrent regions of amplification and deletions, many of which encompassed resident genes that have not been implicated in cancer or metastasis. To identify progression-associated metastasis gene candidates, we applied a statistical approach, Integrative Genome Comparison (IGC), to define 32 genomic regions of interest that were significantly altered in metastatic relative to primary melanomas, encompassing 30 resident genes with statistically significant expression deregulation. Functional assays on a subset of these candidates, including MET, ASPM, AKAP9, IMP3, PRKCA, RPA3, and SCAP2, validated their pro-invasion activities in human melanoma cells. Validity of the IGC approach was further reinforced by tissue microarray analysis of Survivin showing significant increased protein expression in thick versus thin primary cutaneous melanomas, and a progression correlation with lymph node metastases. Together, these functional validation results and correlative analysis of human tissues support the thesis that integrated genomic and pathological analyses of staged melanomas provide a productive entry point for discovery of melanoma metastases genes.

Download full-text


Available from: Stephan N Wagner
  • Source
    • "We made focus on two proteins which have been involved in cell migration: the centrosomal/Golgi scaffold AKAP350 and the cdc42 effector CIP4. AKAP350 has been identified as a crucial participant in cell migration in different cell contexts, including integrin induced T cell migration, and epithelial and melanoma cell migration in experimental wounds (El Din El Homasany et al., 2005; Rivero et al., 2009; Kabbarah et al., 2010). Previous studies suggested that AKAP350 facilitates directional cell migration by enabling microtubule nucleation at the Golgi apparatus (Rivero et al., 2009), which is necessary for proper trafficking of membrane components towards the leading edge (Efimov et al., 2007). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The acquisition of a migratory phenotype is central in processes as diverse as embryo differentiation and tumor metastasis. An early event in this phenomenon is the generation of a nucleus-centrosome-Golgi back to front axis. AKAP350 is a Golgi/centrosome scaffold protein involved in microtubule nucleation. AKAP350 interacts with CIP4, a cdc42 effector that regulates actin dynamics. The present study aimed to characterize the participation of centrosomal AKAP350 in the acquisition of migratory polarity, and the involvement of CIP4 in the pathway. The decrease in total or in centrosomal AKAP350 led to decreased formation of the nucleus-centrosome-Golgi axis and defective cell migration. CIP4 localized at the centrosome. That was enhanced in migratory cells, but inhibited in cells with decreased centrosomal AKAP350. The interference with CIP4 expression or with CIP4/AKAP350 interaction also led to defective cell polarization. Centrosome positioning, but not nuclear movement was affected by loss of CIP4 or AKAP350 function. Our results support a model where AKAP350 recruits CIP4 to the centrosome, providing a centrosomal scaffold to integrate microtubule and actin dynamics, thus enabling centrosome polarization, and ensuring cell migration directionality. © 2015. Published by The Company of Biologists Ltd.
    Full-text · Article · Jul 2015 · Journal of Cell Science
  • Source
    • "It is caused by both genetic defects and environmental factors such as UV exposure [Chin, 2003; Chin et al., 2006; Ghosh and Chin, 2009]. The roles of genetic defects in the carcinogenesis and metastasis have been studied extensively [Kabbarah et al., 2010]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Obesity is now a major health problem due to its rapidly increasing incidence worldwide and severe consequences.Among many conditions associated with obesity aresome cancers including melanoma.Both genetic defects and environmental risk factors are involved in the carcinogenesis of melanoma. Activation of multiple signal pathways such as the PI3K/Akt and MAPK pathways are necessary for the initiation of melanoma. Activation of the MAPK pathway as a result of activating mutations in BRAF is commonly seen in melanoma though it alone is not sufficient to cause malignant transformation of melanocytes. Obesity can result in the activation of many signal pathways including PI3K/Akt, MAPK and STAT3. The activation of these pathways may have a synergistic effect with the genetic defects thereby increasing the incidence of melanoma. J. Cell. Biochem. © 2013 Wiley Periodicals, Inc.
    Full-text · Article · Mar 2013 · Journal of Cellular Biochemistry
  • Source
    • "Imp3 is expressed predominantly during embryogenesis and in various tumors [7]–[14], with its expression being limited to the placenta and testis in normal adult mice [9]. Imp3 is thus considered an oncofetal protein and is highly expressed in various human malignancies [8], [9], [15], [16]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Osteosarcoma is a high-grade malignant bone tumor that manifests ingravescent clinical behavior. The intrinsic events that confer malignant properties on osteosarcoma cells have remained unclear, however. We previously established two lines of mouse osteosarcoma cells: AX cells, which are able to form tumors in syngeneic mice, and AXT cells, which were derived from such tumors and acquired an increased tumorigenic capacity during tumor development. We have now identified Igf2 mRNA-binding protein3 (Imp3) as a key molecule responsible for this increased tumorigenicity of AXT cells in vivo. Imp3 is consistently up-regulated in tumors formed by AX cells, and its expression in these cells was found to confer malignant properties such as anchorage-independent growth, loss of contact inhibition, and escape from anoikis in vitro. The expression level of Imp3 also appeared directly related to tumorigenic ability in vivo which is the critical determination for tumor-initiating cells. The effect of Imp3 on tumorigenicity of osteosarcoma cells did not appear to be mediated through Igf2-dependent mechanism. Our results implicate Imp3 as a key regulator of stem-like tumorigenic characteristics in osteosarcoma cells and as a potential therapeutic target for this malignancy.
    Full-text · Article · Nov 2012 · PLoS ONE
Show more